114 related articles for article (PubMed ID: 3677305)
1. Mechanism of mouse skin tumor promotion by n-dodecane.
Baxter CS; Miller ML
Carcinogenesis; 1987 Dec; 8(12):1787-90. PubMed ID: 3677305
[TBL] [Abstract][Full Text] [Related]
2. Critical comparison of histological and morphometric changes in SENCAR mouse epidermis in response to n-dodecane, 12-O-tetradecanoylphorbol-13-acetate and mezerein.
Miller ML; Andringa A; Baxter CS
Carcinogenesis; 1988 Nov; 9(11):1959-65. PubMed ID: 3180333
[TBL] [Abstract][Full Text] [Related]
3. Comparative histomorphometric changes in SENCAR mouse epidermis in response to multiple treatments with complete and stage-specific tumor promoting agents.
Baxter CS; Andringa A; Chalfin K; Miller ML
Carcinogenesis; 1989 Oct; 10(10):1855-61. PubMed ID: 2791204
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of mezerein-promoted papilloma formation by treatment with 12-O-tetradecanoylphorbol-13-acetate or mezerein prior to initiation.
Ewing MW; Crysup SE; Phillips JL; Slaga TJ; DiGiovanni J
Carcinogenesis; 1988 Mar; 9(3):405-10. PubMed ID: 3125993
[TBL] [Abstract][Full Text] [Related]
5. Further characterization of skin tumor promotion and progression by mezerein in SENCAR mice.
Ewing MW; Conti CJ; Phillips JL; Slaga TJ; DiGiovanni J
J Natl Cancer Inst; 1989 May; 81(9):676-82. PubMed ID: 2496233
[TBL] [Abstract][Full Text] [Related]
6. Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin.
Perchellet JP; Abney NL; Thomas RM; Guislain YL; Perchellet EM
Cancer Res; 1987 Jan; 47(2):477-85. PubMed ID: 3098411
[TBL] [Abstract][Full Text] [Related]
7. Consumption of reduced-energy/low-fat diet or constant-energy/high-fat diet during mezerein treatment inhibited mouse skin tumor promotion.
Birt DF; Pelling JC; Anderson J; Barnett T
Carcinogenesis; 1994 Oct; 15(10):2341-5. PubMed ID: 7955075
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion.
Slaga TJ; Fischer SM; Nelson K; Gleason GL
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3659-63. PubMed ID: 6774342
[TBL] [Abstract][Full Text] [Related]
9. Vitamin E is a complete tumor promoter in mouse skin.
Mitchel RE; McCann R
Carcinogenesis; 1993 Apr; 14(4):659-62. PubMed ID: 8472330
[TBL] [Abstract][Full Text] [Related]
10. 12-O-tetradecanoylphorbol-13-acetate promotes tumors prior to initiation in two-stage promotion.
Ordman AB; Cleaveland JS; Boutwell RK
Cancer Lett; 1985 Oct; 29(1):79-84. PubMed ID: 3933814
[TBL] [Abstract][Full Text] [Related]
11. S/RV Cri-ba, a hairless mouse strain sensitive to skin tumorigenesis by suboptimal doses of 7,12-dimethylbenz[a]anthracene, initiation-promotion and two stage promotion protocols.
Bhisey RA; Veturkar PL
Cancer Lett; 1990 Jun; 52(1):63-9. PubMed ID: 2112980
[TBL] [Abstract][Full Text] [Related]
12. Cholera toxin, a potent inducer of epidermal hyperplasia but with no tumor promoting activity in mouse skin carcinogenesis.
Kuroki T; Chida K; Munakata K; Murakami Y
Biochem Biophys Res Commun; 1986 May; 137(1):486-92. PubMed ID: 3013191
[TBL] [Abstract][Full Text] [Related]
13. The protein kinase C activator L-alpha-dioctanoylglycerol: a potent stage II mouse skin tumor promoter.
Verma AK
Cancer Res; 1988 Apr; 48(7):1736-9. PubMed ID: 3127039
[TBL] [Abstract][Full Text] [Related]
14. Comparison of octahydromezerein and mezerein as protein kinase C activators and as mouse skin tumor promoters.
Sharkey NA; Hennings H; Yuspa SH; Blumberg PM
Carcinogenesis; 1989 Oct; 10(10):1937-41. PubMed ID: 2507191
[TBL] [Abstract][Full Text] [Related]
15. High dietary retinoic acid inhibits tumor promotion and malignant conversion in a two-stage skin carcinogenesis protocol using 7,12-dimethylbenz[a]anthracene as the initiator and mezerein as the tumor promoter in female SENCAR mice.
Chen LC; Tarone R; Huynh M; De Luca LM
Cancer Lett; 1995 Aug; 95(1-2):113-8. PubMed ID: 7656218
[TBL] [Abstract][Full Text] [Related]
16. Effect of tumor-promoting agents on density and morphometric parameters of mouse epidermal Langerhans and Thy-1+ cells.
Baxter CS; Andringa A; Chalfin K; Miller ML
Carcinogenesis; 1991 Jun; 12(6):1017-21. PubMed ID: 1675159
[TBL] [Abstract][Full Text] [Related]
17. Tumorigenesis and carcinogenesis in mouse skin treated with hyperthermia during stage I or stage II of tumor promotion.
Mitchel RE; Morrison DP; Gragtmans NJ
Carcinogenesis; 1987 Dec; 8(12):1875-9. PubMed ID: 3119245
[TBL] [Abstract][Full Text] [Related]
18. Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters.
Fischer SM; O'Connell JF; Conti CJ; Tacker KC; Fries JW; Patrick KE; Adams LM; Slaga TJ
Carcinogenesis; 1987 Mar; 8(3):421-4. PubMed ID: 3545526
[TBL] [Abstract][Full Text] [Related]
19. alpha-Difluoromethylornithine, an irreversible inhibitor of ornithine decarboxylase, inhibits tumor promoter-induced polyamine accumulation and carcinogenesis in mouse skin.
Weeks CE; Herrmann AL; Nelson FR; Slaga TJ
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):6028-32. PubMed ID: 6821130
[TBL] [Abstract][Full Text] [Related]
20. Induction of papillomas with a high probability of conversion to malignancy.
Hennings H; Shores R; Mitchell P; Spangler EF; Yuspa SH
Carcinogenesis; 1985 Nov; 6(11):1607-10. PubMed ID: 2414025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
